Inverse association between docosahexaenoic acid and mortality in patients on hemodialysis during over 10 years

Hemodialysis International

Volumn 18, Issue 3, 2014, Pages 625-631

  Terashima, Yoshihiro ^a   Hamazaki, Kei ^a   Itomura, Miho ^b   Tomita, Shin ^b   Kuroda, Masahiro ^c   Hirata, Hitoshi ^d   Hamazaki, Tomohito ^b   Inadera, Hidekuni ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b Toyama Jounan Daini Hospital   (Japan)

^c Asanagi Hospital   (Japan)

^d Jounan Clinic   (Japan)

Author keywords

All cause mortality; Cohort study; Long term hemodialysis; N 3 polyunsaturated fatty acids

Indexed keywords

DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID; OLEIC ACID; PALMITOLEIC ACID; STEARIC ACID;

ADULT; AGED; AORTA DISEASE; ARTICLE; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIETARY INTAKE; ERYTHROCYTE; FATTY ACID ANALYSIS; FEMALE; FOLLOW UP; GAS CHROMATOGRAPHY; GASTROINTESTINAL DISEASE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFECTION; ISCHEMIC HEART DISEASE; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; INCIDENCE; PROCEDURES; RENAL REPLACEMENT THERAPY; RISK FACTOR;

AGED; COHORT STUDIES; DOCOSAHEXAENOIC ACIDS; FEMALE; HUMANS; INCIDENCE; MALE; RENAL DIALYSIS; RISK FACTORS;

EID: 84904036655     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/hdi.12128     Document Type: Article

References (33)

1. Roberts MA, Polkinghorne KR, McDonald SP, Ierino FL. Secular trends in cardiovascular mortality rates of patients receiving dialysis compared with the general population. Am J Kidney Dis. 2011; 58:64-72.
2. De Caterina R. n-3 fatty acids in cardiovascular disease. N Engl J Med. 2011; 364:2439-2450.
3. Aarsetoey H, Grundt H, Nygaard O, Nilsen DW. The role of long-chained marine N-3 polyunsaturated fatty acids in cardiovascular disease. Cardiol Res Pract. 2012; 2012:303456.
4. Kutner NG, Clow PW, Zhang R, Aviles X. Association of fish intake and survival in a cohort of incident dialysis patients. Am J Kidney Dis. 2002; 39:1018-1024.
5. Friedman AN, Saha C, Watkins BA. Feasibility study of erythrocyte long-chain omega-3 polyunsaturated fatty acid content and mortality risk in hemodialysis patients. J Ren Nutr. 2008; 18:509-512.
6. Shoji T, Kakiya R, Hayashi T, etal. Serum n-3 and n-6 polyunsaturated fatty acid profile as an independent predictor of cardiovascular events in hemodialysis patients. Am J Kidney Dis. 2013; 62:568-576.
7. Friedman AN, Yu Z, Tabbey R, etal. Inverse relationship between long-chain n-3 fatty acids and risk of sudden cardiac death in patients starting hemodialysis. Kidney Int. 2013; 83:1130-1135.
8. Svensson M, Schmidt EB, Jorgensen KA, Christensen JH. N-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: A randomized, placebo-controlled intervention trial. Clin J Am Soc Nephrol. 2006; 1:780-786.
9. Lok CE, Moist L, Hemmelgarn BR, etal. Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: A randomized controlled trial. JAMA. 2012; 307:1809-1816.
10. Hamazaki K, Terashima Y, Itomura M, etal. The relationship between n-3 long-chain polyunsaturated fatty acids and pulse wave velocity in diabetic and non-diabetic patients under long-term hemodialysis. A horizontal study. Clin Nephrol. 2009; 71:508-513.
11. Hamazaki K, Terashima Y, Itomura M, etal. Docosahexaenoic acid is an independent predictor of all-cause mortality in hemodialysis patients. Am J Nephrol. 2011; 33:105-110.
12. Hamazaki K, Itomura M, Huan M, etal. Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: A randomized, placebo-controlled, double-blind trial. Nutrition. 2005; 21:705-710.
13. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959; 37:911-917.
14. Nishizawa H, Hamazaki K, Hamazaki T, Fujioka S, Sawazaki S. The relationship between tissue RBC n-3 fatty acids and pulse wave velocity. In Vivo. 2006; 20:307-310.
15. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999; 99:2434-2439.
16. Nakai S, Iseki K, Itami N, etal. An overview of regular dialysis treatment in Japan (as of 31 December 2010). Ther Apher Dial. 2012; 16:483-521.
17. Tavazzi L, Maggioni AP, Marchioli R, etal. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): A randomised, double-blind, placebo-controlled trial. Lancet. 2008; 372:1223-1230.
18. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet. 1999; 354:447-455.
19. Albert CM, Campos H, Stampfer MJ, etal. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002; 346:1113-1118.
20. System USRD. USRDS 2012 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2012.
21. Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res. 2008; 47:348-380.
22. Finks SW, Airee A, Chow SL, etal. Key articles of dietary interventions that influence cardiovascular mortality. Pharmacotherapy. 2012; 32:e54-e87.
23. Ahmad Nizar NN, Nazrim Marikkar JM, Hashim DM. Differentiation of lard: Chicken fat: Beef fat and mutton fat by GCMS and EA-IRMS techniques. J Oleo Sci. 2013; 62:459-464.
24. Jump DB, Botolin D, Wang Y, Xu J, Christian B, Demeure O. Fatty acid regulation of hepatic gene transcription. J Nutr. 2005; 135:2503-2506.
25. Miyazaki M, Bruggink SM, Ntambi JM. Identification of mouse palmitoyl-coenzyme A Delta9-desaturase. J Lipid Res. 2006; 47:700-704.
26. Oh JS, Kim SM, Sin YH, etal. Comparison of erythrocyte membrane fatty acid contents in renal transplant recipients and dialysis patients. Transplant Proc. 2012; 44:2932-2935.
27. Son YK, Lee SM, Kim SE, etal. Association between vascular calcification scores on plain radiographs and fatty acid contents of erythrocyte membrane in hemodialysis patients. J Ren Nutr. 2012; 22:58-66.
28. Garg ML, Blake RJ, Wills RB. Macadamia nut consumption lowers plasma total and LDL cholesterol levels in hypercholesterolemic men. J Nutr. 2003; 133:1060-1063.
29. Griel AE, Cao Y, Bagshaw DD, Cifelli AM, Holub B, Kris-Etherton PM. A macadamia nut-rich diet reduces total and LDL-cholesterol in mildly hypercholesterolemic men and women. J Nutr. 2008; 138:761-767.
30. Hiraoka-Yamamoto J, Ikeda K, Negishi H, etal. Serum lipid effects of a monounsaturated (palmitoleic) fatty acid-rich diet based on macadamia nuts in healthy, young Japanese women. Clin Exp Pharmacol Physiol. 2004; 31(Suppl 2):S37-S38.
31. Wu JH, Lemaitre RN, Imamura F, etal. Fatty acids in the de novo lipogenesis pathway and risk of coronary heart disease: The Cardiovascular Health Study. Am J Clin Nutr. 2011; 94:431-438.
32. Lucchi L, Banni S, Iannone A, etal. Changes in conjugated linoleic acid and palmitoleic acid are correlated to retinol levels in chronic renal failure in both hemodialysis and conservative treatment patients. Artif Organs. 2005; 29:413-418.
33. An overview of regular dialysis treatment in Japan (as of 31 December 2002). Ther Apher Dial. 2004; 8:358-382.